Co-Diagnostics/$CODX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Co-Diagnostics
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Ticker
$CODX
Sector
Primary listing
Employees
132
Headquarters
Website
Co-Diagnostics Metrics
BasicAdvanced
$12M
-
-$1.14
0.52
-
Price and volume
Market cap
$12M
Beta
0.52
52-week high
$0.68
52-week low
$0.23
Average daily volume
3.9M
Financial strength
Current ratio
4.125
Quick ratio
3.657
Long term debt to equity
2.137
Total debt to equity
4.141
Profitability
EBITDA (TTM)
-37.471
Gross margin (TTM)
39.60%
Net profit margin (TTM)
-3,586.00%
Operating margin (TTM)
-3,860.88%
Effective tax rate (TTM)
-0.11%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-38.09%
Return on equity (TTM)
-63.40%
Valuation
Price to revenue (TTM)
10.052
Price to book
0.28
Price to tangible book (TTM)
0.77
Price to free cash flow (TTM)
-0.304
Free cash flow yield (TTM)
-329.44%
Free cash flow per share (TTM)
-1.051
Growth
Revenue change (TTM)
-89.02%
Earnings per share change (TTM)
-9.68%
3-year revenue growth (CAGR)
-76.59%
3-year earnings per share growth (CAGR)
8.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Co-Diagnostics stock?
Co-Diagnostics (CODX) has a market cap of $12M as of August 23, 2025.
What is the P/E ratio for Co-Diagnostics stock?
The price to earnings (P/E) ratio for Co-Diagnostics (CODX) stock is 0 as of August 23, 2025.
Does Co-Diagnostics stock pay dividends?
No, Co-Diagnostics (CODX) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next Co-Diagnostics dividend payment date?
Co-Diagnostics (CODX) stock does not pay dividends to its shareholders.
What is the beta indicator for Co-Diagnostics?
Co-Diagnostics (CODX) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.